Bayer CropScience Ltd
Bayer CropScience is engaged in Agri Care business which primarily includes manufacture, sale and distribution of insecticides, fungicides, herbicide and various other agrochemical products and corn seeds.[1]
- Market Cap ₹ 29,605 Cr.
- Current Price ₹ 6,587
- High / Low ₹ 7,197 / 4,813
- Stock P/E 44.4
- Book Value ₹ 634
- Dividend Yield 2.13 %
- ROCE 33.9 %
- ROE 26.7 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
- Company has a good return on equity (ROE) track record: 3 Years ROE 25.5%
- Company has been maintaining a healthy dividend payout of 88.8%
Cons
- Stock is trading at 10.4 times its book value
- The company has delivered a poor sales growth of 10.0% over past five years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Agro Chemicals Industry: Pesticides / Agrochemicals - Multinational
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2,682 | 3,188 | 3,660 | 2,769 | 2,803 | 2,710 | 3,167 | 3,609 | 4,261 | 4,734 | 5,140 | 5,103 | 4,995 | |
2,321 | 2,768 | 3,144 | 2,334 | 2,389 | 2,300 | 2,684 | 2,883 | 3,450 | 3,923 | 4,216 | 4,147 | 4,151 | |
Operating Profit | 362 | 419 | 516 | 435 | 414 | 410 | 483 | 726 | 812 | 812 | 924 | 956 | 843 |
OPM % | 13% | 13% | 14% | 16% | 15% | 15% | 15% | 20% | 19% | 17% | 18% | 19% | 17% |
1,242 | 91 | 88 | 82 | 70 | 39 | 51 | -64 | 69 | 112 | 168 | 79 | 88 | |
Interest | 4 | 5 | 5 | 10 | 7 | 11 | 10 | 14 | 13 | 13 | 22 | 20 | 16 |
Depreciation | 37 | 65 | 25 | 25 | 29 | 33 | 44 | 65 | 74 | 64 | 80 | 74 | 64 |
Profit before tax | 1,563 | 441 | 574 | 482 | 448 | 404 | 480 | 583 | 794 | 847 | 990 | 941 | 851 |
Tax % | 26% | 34% | 33% | 35% | 35% | 26% | 30% | 19% | 38% | 24% | 23% | 21% | |
1,162 | 290 | 383 | 315 | 291 | 300 | 337 | 474 | 493 | 645 | 758 | 740 | 666 | |
EPS in Rs | 294.11 | 79.06 | 104.59 | 89.13 | 82.31 | 87.41 | 98.18 | 105.58 | 109.72 | 143.58 | 168.71 | 164.77 | 148.24 |
Dividend Payout % | 2% | 7% | 20% | 19% | 21% | 21% | 18% | 24% | 105% | 104% | 77% | 85% |
Compounded Sales Growth | |
---|---|
10 Years: | 5% |
5 Years: | 10% |
3 Years: | 6% |
TTM: | -4% |
Compounded Profit Growth | |
---|---|
10 Years: | 10% |
5 Years: | 17% |
3 Years: | 15% |
TTM: | -6% |
Stock Price CAGR | |
---|---|
10 Years: | 11% |
5 Years: | 15% |
3 Years: | 8% |
1 Year: | 22% |
Return on Equity | |
---|---|
10 Years: | 21% |
5 Years: | 24% |
3 Years: | 25% |
Last Year: | 27% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 40 | 37 | 37 | 35 | 35 | 34 | 34 | 45 | 45 | 45 | 45 | 45 |
Reserves | 1,892 | 1,706 | 1,996 | 1,804 | 2,021 | 1,744 | 2,205 | 2,528 | 2,505 | 2,479 | 2,667 | 2,804 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 26 | 86 | 74 | 47 | |
484 | 645 | 740 | 597 | 769 | 756 | 1,310 | 1,262 | 1,663 | 1,742 | 1,893 | 1,701 | |
Total Liabilities | 2,415 | 2,387 | 2,773 | 2,437 | 2,825 | 2,535 | 3,549 | 3,836 | 4,239 | 4,353 | 4,679 | 4,597 |
219 | 228 | 322 | 290 | 342 | 334 | 440 | 468 | 425 | 468 | 462 | 414 | |
CWIP | 127 | 217 | 1 | 17 | 24 | 36 | 47 | 56 | 76 | 98 | 109 | 119 |
Investments | 4 | 4 | 29 | 68 | 50 | 0 | 0 | 41 | 52 | 38 | 41 | 54 |
2,066 | 1,939 | 2,422 | 2,062 | 2,410 | 2,164 | 3,062 | 3,270 | 3,686 | 3,749 | 4,066 | 4,010 | |
Total Assets | 2,415 | 2,387 | 2,773 | 2,437 | 2,825 | 2,535 | 3,549 | 3,836 | 4,239 | 4,353 | 4,679 | 4,597 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
138 | 282 | 200 | 206 | 157 | 121 | 433 | 666 | 687 | 216 | 609 | 952 | |
427 | -290 | 485 | 16 | -8 | 38 | -113 | -29 | 7 | 64 | 83 | 0 | |
-21 | -480 | -42 | -590 | -73 | -581 | -158 | -148 | -556 | -703 | -613 | -656 | |
Net Cash Flow | 544 | -488 | 644 | -367 | 76 | -421 | 162 | 489 | 138 | -424 | 79 | 296 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 44 | 47 | 57 | 53 | 72 | 89 | 81 | 73 | 65 | 77 | 69 | 69 |
Inventory Days | 106 | 98 | 85 | 169 | 178 | 175 | 294 | 206 | 226 | 235 | 268 | 222 |
Days Payable | 42 | 51 | 40 | 52 | 67 | 67 | 164 | 101 | 142 | 127 | 129 | 87 |
Cash Conversion Cycle | 108 | 94 | 102 | 171 | 184 | 197 | 211 | 177 | 149 | 185 | 208 | 204 |
Working Capital Days | 79 | 88 | 53 | 92 | 104 | 134 | 116 | 77 | 62 | 87 | 89 | 80 |
ROCE % | 29% | 24% | 31% | 25% | 23% | 22% | 25% | 30% | 31% | 31% | 34% | 34% |
Documents
Announcements
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
13h - Certificate under Regulation 74(5) for Q3 2024.
- Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate 30 Sep
- Closure of Trading Window 23 Sep
-
Disclosure Pursuant To Regulation 30 Of The SEBI (LODR) Regulations, 2015
20 Sep - Company fined Rs. 10,000 for Insecticides Act violation.
- Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate 20 Sep
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Concalls
-
Aug 2024Transcript PPT
-
Jun 2023Transcript PPT
-
Jun 2022Transcript PPT
-
Nov 2021Transcript PPT
-
May 2021TranscriptNotesPPT
-
Nov 2020TranscriptNotesPPT
-
May 2020TranscriptNotesPPT
-
Nov 2019TranscriptNotesPPT
-
May 2019TranscriptNotesPPT
-
Nov 2018TranscriptNotesPPT
-
Jun 2018TranscriptNotesPPT
-
Aug 2017TranscriptNotesPPT
-
Feb 2017TranscriptNotesPPT
-
Jul 2016TranscriptNotesPPT
-
Nov 2015TranscriptNotesPPT
Business Areas